{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:29:52Z","timestamp":1776986992890,"version":"3.51.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2&3","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>In humans, there is profound individual variation in the risk of alcohol use disorder (AUD). Because GABA, opioid and glutamate neurotransmission have been implicated in AUD, functional differences in these neural systems may underlie the individual vulnerability to AUD. We therefore determined the effects of drugs affecting GABA, opioid and glutamatergic neurotransmission on alcohol consumption in rats that differed in baseline alcohol intake. Subgroups of low-, medium- and high-alcohol-drinking rats were selected on the basis of alcohol consumption using an intermittent alcohol access procedure. The subgroups were treated with the GABA<jats:sub>B<\/jats:sub> receptor agonist baclofen, the opioid receptor antagonist naltrexone and the cysteine precursor <jats:italic toggle=\"yes\">N<\/jats:italic>-acetylcysteine, and the effects on alcohol intake and preference were determined. Both baclofen and naltrexone reduced alcohol consumption, but <jats:italic toggle=\"yes\">N<\/jats:italic>-acetylcysteine did not. These effects were comparable for low-, medium- and high-alcohol-drinking rats. However, there was a substantial degree of individual variation in the responsivity to baclofen and naltrexone, across the subgroups. Taken together, these results suggest that variation in alcohol consumption does not predict the responsivity to baclofen and naltrexone. This implies that individual variability in alcohol consumption on the one hand and sensitivity to treatment with these drugs on the other hand represent separate processes that likely involve distinct biological mechanisms.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000615","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T16:30:08Z","timestamp":1607963408000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Baclofen and naltrexone, but not N-acetylcysteine, affect voluntary alcohol drinking in rats regardless of individual levels of alcohol intake"],"prefix":"10.1097","volume":"32","author":[{"given":"A. Maryse","family":"Minnaard","sequence":"first","affiliation":[{"name":"Department of Population Health Sciences, Unit Animals in Science and Society, Faculty of Veterinary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert M.J.","family":"Ramakers","sequence":"additional","affiliation":[{"name":"Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louk J.M.J.","family":"Vanderschuren","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Unit Animals in Science and Society, Faculty of Veterinary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.B.","family":"Lesscher","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Unit Animals in Science and Society, Faculty of Veterinary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"R1-20250614","first-page":"67","article-title":"Ability of baclofen in reducing alcohol craving and intake: II\u2013Preliminary clinical evidence.","volume":"24","author":"Addolorato","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1530-0277.2003.tb04414.x","article-title":"Effect of baclofen on alcohol and sucrose self-administration in rats.","volume":"27","author":"Anstrom","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"e1439","DOI":"10.4088\/JCP.15m10239","article-title":"A Double-blind, randomized, controlled pilot trial of N-acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders.","volume":"77","author":"Back","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopsych.2009.07.026","article-title":"Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.","volume":"67","author":"Barr","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial.","volume":"26","author":"Beraha","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopsych.2014.08.021","article-title":"A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.","volume":"77","author":"Bilbao","year":"2015","journal-title":"Biol Psychiatry"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2005.09.011","article-title":"Differential G-protein coupling to GABAB receptor in limbic areas of alcohol-preferring and -nonpreferring rats.","volume":"523","author":"Castelli","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R10-20250614","first-page":"58","article-title":"Ability of baclofen in reducing alcohol intake and withdrawal severity: I\u2013Preclinical evidence.","volume":"24","author":"Colombo","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0376-8716(02)00333-2","article-title":"Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats.","volume":"70","author":"Colombo","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(15)00122-1","article-title":"Alcohol use disorders.","volume":"387","author":"Connor","year":"2016","journal-title":"Lancet"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1037\/0735-7044.118.5.1089","article-title":"Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone.","volume":"118","author":"Coonfield","year":"2004","journal-title":"Behav Neurosci"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.pbb.2011.06.004","article-title":"The response to naltrexone in ethanol-drinking rats depends on early environmental experiences.","volume":"99","author":"Daoura","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0741-8329(87)90087-5","article-title":"GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats.","volume":"4","author":"Daoust","year":"1987","journal-title":"Alcohol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3565(25)12080-6","article-title":"Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats.","volume":"275","author":"de Waele","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/01.ALC.0000141640.48924.14","article-title":"Baclofen for alcohol dependence: a preliminary open-label study.","volume":"28","author":"Flannery","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"R19-20250614","first-page":"120","article-title":"Alcohol and glutamate.","volume":"21","author":"Gonzales","year":"1997","journal-title":"Alcohol Health Res World"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.","volume":"21","author":"Hein\u00e4l\u00e4","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.07.017","article-title":"Increased ethanol drinking in \u201chumanized\u201d mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.","volume":"138","author":"Henderson-Redmond","year":"2018","journal-title":"Brain Res Bull"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0741-8329(03)00068-5","article-title":"Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose.","volume":"30","author":"Janak","year":"2003","journal-title":"Alcohol"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1369-1600.2007.00073.x","article-title":"Cloninger\u2019s typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.","volume":"13","author":"Kiefer","year":"2008","journal-title":"Addict Biol"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2019.03.010","article-title":"Evaluation of N-acetylcysteine on ethanol self-administration in ethanol-dependent rats.","volume":"150","author":"Lebourgeois","year":"2019","journal-title":"Neuropharmacology"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/adb.12521","article-title":"Effect of N-acetylcysteine on motivation, seeking and relapse to ethanol self-administration.","volume":"23","author":"Lebourgeois","year":"2018","journal-title":"Addict Biol"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1530-0277.2012.01782.x","article-title":"Comparison of the effect of the GABA\u0392 receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.","volume":"36","author":"Maccioni","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0024-3205(00)00517-8","article-title":"Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats.","volume":"66","author":"Marinelli","year":"2000","journal-title":"Life Sci"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0741-8329(98)00021-4","article-title":"Quantitative autoradiography of mu-opioid receptors in the CNS of alcohol-naive alcohol-preferring P and -nonpreferring NP rats.","volume":"16","author":"McBride","year":"1998","journal-title":"Alcohol"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"211","DOI":"10.15288\/jsa.2001.62.211","article-title":"How effective is alcoholism treatment in the United States?","volume":"62","author":"Miller","year":"2001","journal-title":"J Stud Alcohol"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2014.08.058","article-title":"Subgroup-dependent effects of voluntary alcohol intake on behavioral profiles in outbred Wistar rats.","volume":"275","author":"Momeni","year":"2014","journal-title":"Behav Brain Res"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fnins.2015.00424","article-title":"Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats.","volume":"9","author":"Momeni","year":"2015","journal-title":"Front Neurosci"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1360-0443.2006.01310.x","article-title":"Rates and predictors of relapse after natural and treated remission from alcohol use disorders.","volume":"101","author":"Moos","year":"2006","journal-title":"Addiction"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.euroneuro.2015.04.002","article-title":"High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.","volume":"25","author":"M\u00fcller","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence. A controlled study.","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"RC184","DOI":"10.1523\/JNEUROSCI.21-23-j0002.2001","article-title":"Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine.","volume":"21","author":"Olive","year":"2001","journal-title":"J Neurosci"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2018.03.017","article-title":"Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: a systematic review and meta-analysis.","volume":"28","author":"Pierce","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/acer.13031","article-title":"Beyond the \u201cfirst hit\u201d: marked inhibition by N-acetyl cysteine of chronic ethanol intake but not of early ethanol intake. Parallel effects on ethanol-induced saccharin motivation.","volume":"40","author":"Quintanilla","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1073\/pnas.0437926100","article-title":"Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons.","volume":"100","author":"Roberto","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1530-0277.2008.00753.x","article-title":"Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats.","volume":"32","author":"Simms","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s00213-016-4330-x","article-title":"Dopamine receptor agonists modulate voluntary alcohol intake independently of individual levels of alcohol intake in rats.","volume":"233","author":"Spoelder","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/FBP.0000000000000304","article-title":"Loss of control over alcohol seeking in rats depends on individual vulnerability and duration of alcohol consumption experience.","volume":"28","author":"Spoelder","year":"2017","journal-title":"Behav Pharmacol"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/acer.12891","article-title":"Individual variation in alcohol intake predicts reinforcement, motivation, and compulsive alcohol use in rats.","volume":"39","author":"Spoelder","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2017.12.005","article-title":"The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.","volume":"185","author":"Squeglia","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"173037","DOI":"10.1016\/j.pbb.2020.173037","article-title":"Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol.","volume":"198","author":"Stoops","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1176\/ajp.152.3.332","article-title":"The glutamatergic basis of human alcoholism.","volume":"152","author":"Tsai","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugalcdep.2010.01.005","article-title":"A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys.","volume":"109","author":"Vallender","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1874473711205010003","article-title":"Evidence-based pharmacological treatment of substance use disorders and pathological gambling.","volume":"5","author":"van den Brink","year":"2012","journal-title":"Curr Drug Abuse Rev"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence.","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1530-0277.2006.00259.x","article-title":"The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats.","volume":"31","author":"Walker","year":"2007","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:04:07Z","timestamp":1749938647000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":50,"journal-issue":{"issue":"2&3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000615","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,11]]}}}